Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The 2014 Garrod Lecture: EUCAST – are we heading towards international agreement?

18 Jun 2015

Abstract excerpt

Antimicrobial susceptibility testing with phenotypic methods is based on the measurement of the MIC (mg/L) and breakpoints to categorize bacteria and fungi as susceptible, intermediate or resistant. Phenotypic antimicrobial susceptibility testing requires an agreement on breakpoints and a rigorous standardization of methods and materials. Requirements for defining breakpoints include a definition of doses and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Antibiotics Pharmacokinetics and Efficacy
Share to Bacterial Identification and Susceptibility Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26089441
DOI: 10.1093/jac/dkv145

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The 2014 Garrod Lecture: EUCAST – are we heading towards international agreement?PMID 26089441Read ↗

European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteriaSemantic proximity Read ↗

Antimicrobial susceptibility testing breakpoints and methods from BSAC to EUCASTSemantic proximity Read ↗

Setting Antimicrobial Susceptibility Testing Breakpoints: A Primer for Pediatric Infectious Diseases Specialists on the Clinical and Laboratory Standards Institute ApproachSemantic proximity Read ↗

Susceptibility testing methods, resistance and breakpoints: what do these terms really mean?Semantic proximity Read ↗

Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values—laboratory and clinical utilitySemantic proximity Read ↗

Introducing the new face of CLSI M100 in 2023: An explanatory reviewSemantic proximity Read ↗

Establishing MIC breakpoints and the interpretation of <i>in vitro</i> susceptibility testsSemantic proximity Read ↗

Amoxicillin-Clavulanate Breakpoints AgainstEnterobacterales: Rationale for Revision by the Clinical and Laboratory Standards InstituteSemantic proximity Read ↗

The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approachSemantic proximity Read ↗

A Pragmatic Approach to Susceptibility Classification of Yeasts without EUCAST Clinical BreakpointsSemantic proximity Read ↗

Twenty Years in EUCAST Anti-Fungal Susceptibility Testing: Progress & Remaining ChallengesSemantic proximity Read ↗

Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against EnterobacteralesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.